C4 Therapeutics, Inc. (CCCC)

C4 Therapeutics Revenue

In the year 2024, C4 Therapeutics had annual revenue of $35.58M with 71.44% growth. C4 Therapeutics had revenue of $5.18M in the quarter ending December 31, 2024, with 58.75% growth.

• Revenue (ttm): $35.58M
• Revenue Growth: +71.44%
• P/S Ratio: 3.41
• Revenue / Employee: $323,491
• Employees: 110
• Market Cap: 116.42M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	35.58M	14.83M	71.44%
Dec 31, 2023	20.76M	-10.34M	-33.25%
Dec 31, 2022	31.10M	-14.69M	-32.08%
Dec 31, 2021	45.79M	12.59M	37.93%
Dec 31, 2020	33.20M	11.81M	55.25%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.